THE LEVEL OF TRANSFORMING GROWTH FACTOR-β1 IN PATIENTS WITH BRONCHIAL ASTHMA IN RELATION TO BODY MASS INDEX AND AGE OF ONSET

Authors

  • V. V. Kachkovska Sumy State University

DOI:

https://doi.org/10.11603/1811-2471.2023.v.i4.14302

Keywords:

bronchial asthma, obesity, transforming growth factor-β1, course, control

Abstract

SUMMARY. The study of transforming growth factor-β1 (TGF-β1) in bronchial asthma (BA) is essential due to its role as a pleiotropic and multifunctional growth factor, regulating immune reactions that lead to fibrosis.

The aim – to determine TGF-β1 levels in BA patients, considering BMI, age of onset, clinical and functional characteristics.

Material and Methods. 553 patients with BA were examined. The control group included 95 healthy individuals with no history of asthma, allergies, or atopy in their personal or family records. All participants in the study signed an consent form prior to their participation, indicating their prior informed consent. To determine the content of TGF-β1, depending on BMI, patients were divided into three groups: Group I consisted of 152 patients with normal body weight (NBW), II – 206 overweight patients, III – 195 – with obesity. For the analysis, two groups were formed depending on the age of onset: 1st group included 271 patients with early-onset asthma (including 100 obese patients), 2nd group – 282 late-onset patients (95 with obesity).

Results. A significantly higher level of TGF-β1 was found in patients with BA with different body mass compared to controls; in the presence of obesity compared to that with patients with NBW; in patients with early BA with NBW, overweight and obesity compared to patients with late BA. The level of TGF-β1 was significantly higher in patients with early and late BA with obesity and a severe course compared to non-severe ones, and in patients with early BA with obesity and a severe course, it was 1.9 times higher than the similar indicator in patients with late BA with obesity and severe course

Conclusions. As the duration and severity of BA increased, the level of TGF-β1 also rose in patients. Additionally, patients with early-onset BA had higher levels of this biomarker than those with late-onset. This suggests that TGF-β1 could play an important role in studying airway remodeling among this group of patients, taking into account their age of onset.

References

Woo, J., Koziol-White, C., Panettieri, R., Jr, & Jude, J. (2021). TGF-β: The missing link in obesity-associated airway diseases? Current research in pharmacology and drug discovery, 2. DOI: 10.1016/j.crphar.2021.100016. DOI: https://doi.org/10.1016/j.crphar.2021.100016

Park, Y.H., Oh, E.Y., Han, H., Yang, M., Park, H.J., Park, K.H., Lee, J.H., & Park, J.W. (2019). Insulin resistance mediates high-fat diet-induced pulmonary fibrosis and airway hyperresponsiveness through the TGF-β1 pathway. Experimental & molecular medicine, 51(5), 1-12. DOI: 10.1038/ s12276-019-0258-7. DOI: https://doi.org/10.1038/s12276-019-0258-7

E-Lacerda, R.R., Anhê, G.F., Page, C.P., & Riffo-Vasquez, Y. (2020). Sex differences in the influence of obesity on a murine model of allergic lung inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 50(2), 256-266. DOI: 10.1111/cea.13541. DOI: https://doi.org/10.1111/cea.13541

Wnuk, D., Paw, M., Ryczek, K., Bochenek, G., Sładek, K., Madeja, Z., & Michalik, M. (2020). Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment. Scientific reports, 10(1), 16492. DOI: 10.1038/s41598-020-73473-7. DOI: https://doi.org/10.1038/s41598-020-73473-7

Ottobelli Chielle, E., Muller Ogliari, V. C., de Carvalho, D., & Pertile Remor, A. (2018). Influence of obesity and overweight on transforming growth factor beta 1 levels and other oxidative and cardiometabolic parameters. Clinical and Biomedical Research, 38(3). Retrieved from: https://seer.ufrgs.br/index.php/hcpa/article/view/79449. DOI: https://doi.org/10.4322/2357-9730.79449

Farzan, S., Coyle, T., Coscia, G., Rebaza, A., & Santiago, M. (2022). Clinical Characteristics and Management Strategies for Adult Obese Asthma Patients. Journal of asthma and allergy, 15, 673-689. DOI: 10.2147/JAA.S285738. DOI: https://doi.org/10.2147/JAA.S285738

Holguin, F., Bleecker, E.R., Busse, W.W., Calhoun, W.J., Castro, M., Erzurum, S.C., ... & Wenzel, S.E. (2011). Obesity and asthma: an association modified by age of asthma onset. The Journal of allergy and clinical immunology, 127(6), 1486-93. DOI: 10.1016/j.jaci.2011.03.036. DOI: https://doi.org/10.1016/j.jaci.2011.03.036

Ilmarinen, P., Vähätalo, I., Tuomisto, L.E., Niemelä, O., & Kankaanranta, H. (2021). Long-term adherence to inhaled corticosteroids in clinical phenotypes of adult-onset asthma. The journal of allergy and clinical immunology. In practice, 9(9), 3503-3505. DOI: 10.1016/j.jaip.2021.04.057. DOI: https://doi.org/10.1016/j.jaip.2021.04.057

Tan, D. J., Walters, E.H., Perret, J.L., Lodge, C.J., Lowe, A.J., Matheson, M.C., & Dharmage, S.C. (2015). Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature. Expert review of respiratory medicine, 9(1), 109-123. DOI: 10.1586/17476348.2015.1000311. DOI: https://doi.org/10.1586/17476348.2015.1000311

Global Initiative for Asthma. Global strategy for asthma management and prevention 2014. Retrieved from: https://ginasthma.org/wp-content/uploads/2019/01/2014-GINA.pdf.

Aschner, Y., & Downey, G.P. (2016). Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease. American journal of respiratory cell and molecular biology, 54(5), 647-655. DOI: 10.1165/rcmb.2015-0391TR. DOI: https://doi.org/10.1165/rcmb.2015-0391TR

Koćwin, M., Jonakowski, M., Przemęcka, M., Zioło, J., Panek, M., & Kuna, P. (2016). The role of the TGF-SMAD signalling pathway in the etiopathogenesis of severe asthma. Pneumonologia i alergologia polska, 84(5), 290-301. DOI: 10.5603/PiAP.2016.0037. DOI: https://doi.org/10.5603/PiAP.2016.0037

Liu, Z., Li, J., Wang, K., Tan, Q., Tan, W., & Guo, G. (2018). Association Between TGF-β1 Polymorphisms and Asthma Susceptibility Among the Chinese: A Meta-Analysis. Genetic testing and molecular biomarkers, 22(7), 433-442. DOI: 10.1089/gtmb.2017.0238. DOI: https://doi.org/10.1089/gtmb.2017.0238

Zhang, Y., Tang, H., Yuan, X., Ran, Q., Wang, X., Song, Q., Zhang, L., Qiu, Y., & Wang, X. (2018). TGF-β3 Promotes MUC5AC Hyper-Expression by Modulating Autophagy Pathway in Airway Epithelium. EBioMedicine, 33, 242-252. DOI: 10.1016/j.ebiom.2018.06.032. DOI: https://doi.org/10.1016/j.ebiom.2018.06.032

Al-Alawi, M., Hassan, T., & Chotirmall, S.H. (2014). Transforming growth factor β and severe asthma: a perfect storm. Respiratory medicine, 108(10), 1409-1423. DOI: 10. 1016/ j.rmed.2014.08.008. DOI: https://doi.org/10.1016/j.rmed.2014.08.008

Park, J.W. (2022). Asthma Phenotype with Metabolic Dysfunction. Yonsei medical journal, 63(1), 1-7. DOI: 10.3349/ymj.2022.63.1.1. DOI: https://doi.org/10.3349/ymj.2022.63.1.1

McBrien, C.N., & Menzies-Gow, A. (2017). The Biology of Eosinophils and Their Role in Asthma. Frontiers in medicine, 4, 93. DOI: 10.3389/fmed.2017.00093. DOI: https://doi.org/10.3389/fmed.2017.00093

Ojiaku, C.A., Cao, G., Zhu, W., Yoo, E.J., Shumyatcher, M., Himes, B.E., An, S.S., & Panettieri, R.A., Jr. (2018). TGF-β1 Evokes Human Airway Smooth Muscle Cell Shortening and Hyperresponsiveness via Smad3. American journal of respiratory cell and molecular biology, 58(5), 575-584. DOI: 10.1165/rcmb.2017-0247OC. DOI: https://doi.org/10.1165/rcmb.2017-0247OC

Ojiaku, C.A., Chung, E., Parikh, V., Williams, J.K., Schwab, A., Fuentes, A.L., ... & Panettieri, R.A. (2019). Transforming Growth Factor-β1 Decreases β2-Agonist-induced Relaxation in Human Airway Smooth Muscle. American journal of respiratory cell and molecular biology, 61(2), 209-218. DOI: 10.1165/rcmb.2018-0301OC. DOI: https://doi.org/10.1165/rcmb.2018-0301OC

Maffeis, L., Agostoni, C.V., Marafon, D.P., Terranova, L., Giavoli, C., Milani, ... & Patria, M.F. (2022). Cytokines Profile and Lung Function in Children with Obesity and Asthma: A Case Control Study. Children (Basel, Switzerland), 9(10), 1462. DOI: 10.3390/children9101462. DOI: https://doi.org/10.3390/children9101462

Januskevicius, A., Vaitkiene, S., Gosens, R., Janulaityte, I., Hoppenot, D., Sakalauskas, R., & Malakauskas, K. (2016). Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in asthma. BMC pulmonary medicine, 16(1), 94. DOI: https://doi.org/10.1186/s12890-016-0254-9

Hassan, N.A.E., Mohamed-Hussein, A.A.R., Mohammed, E.F., Mohamed, O.A.E., & Mohamed, H.O. (2015). Serum Transforming Growth Factor – β1 (TGF-β1) in Asthmatics: Association between Disease Control, Severity and Duration. Biochemistry & Analytical Biochemistry, 4, 200. DOI: 10.4172/2161- 1009.1000200. DOI: https://doi.org/10.1183/13993003.congress-2015.OA1465

Dogu, F., Yildiran, A., & Loglu, D. (2008). Serum Transforming Growth Factor-ß 1(TGF-ß1),Matrix Metalloproteinase-2 (MMP-2),Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitors of Metalloproteinase (TIMP-1) Levels in Childhood Asthma. Turkish Journal of Medical Sciences, 38, 415-419.

Published

2023-12-19

How to Cite

Kachkovska, V. V. (2023). THE LEVEL OF TRANSFORMING GROWTH FACTOR-β1 IN PATIENTS WITH BRONCHIAL ASTHMA IN RELATION TO BODY MASS INDEX AND AGE OF ONSET. Achievements of Clinical and Experimental Medicine, (4), 81–87. https://doi.org/10.11603/1811-2471.2023.v.i4.14302

Issue

Section

Оригінальні дослідження